| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.811 | 0.018 | 0.959 | DNA directed DNA polymerase inhibitor | 0.822 0.016 DB00369 0.801 0.019 DBMET03374 0.847 0.013 DBMET03375 0.959 0.004 DBMET03373 | DBMET03373 | |
| 0.599 | 0.017 | 0.605 | Immunostimulant | 0.512 0.028 DB00369 0.605 0.016 DBMET03374 0.504 0.029 DBMET03375 0.578 0.019 DBMET03373 | DBMET03374 | |
| 0.56 | 0.009 | 0.657 | DNA synthesis inhibitor | 0.569 0.009 DB00369 0.598 0.007 DBMET03374 0.587 0.008 DBMET03375 0.657 0.006 DBMET03373 | DBMET03373 | |
| 0.552 | 0.008 | 0.66 | RNA-directed DNA polymerase inhibitor | 0.637 0.004 DB00369 0.522 0.009 DBMET03374 0.564 0.007 DBMET03375 0.66 0.003 DBMET03373 | DBMET03373 | |
| 0.5 | 0.005 | 0.525 | Bone formation stimulant | 0.487 0.006 DB00369 0.508 0.005 DBMET03374 0.525 0.005 DBMET03375 0.44 0.008 DBMET03373 | DBMET03375 | |
| 0.485 | 0.025 | 0.568 | Immunomodulator | 0.568 0.015 DB00369 0.476 0.027 DBMET03374 0.451 0.031 DBMET03375 0.472 0.027 DBMET03373 | DB00369 | |
| 0.41 | 0.005 | 0.711 | DNA polymerase I inhibitor | 0.464 0.004 DB00369 0.399 0.006 DBMET03374 0.417 0.005 DBMET03375 0.711 0.001 DBMET03373 | DBMET03373 | |
| 0.428 | 0.053 | 0.428 | Immunosuppressant | 0.404 0.061 DB00369 0.424 0.055 DBMET03374 0.391 0.067 DBMET03375 0.371 0.076 DBMET03373 | ||
| 0.401 | 0.028 | 0.442 | DNA damaging | 0.442 0.02 DBMET03374 0.372 0.035 DBMET03375 | DBMET03374 | |
| 0.335 | 0.006 | 0.739 | DNA directed RNA polymerase inhibitor | 0.517 0.004 DB00369 0.335 0.006 DBMET03374 0.403 0.005 DBMET03375 0.739 0.003 DBMET03373 | DBMET03373 | |
| 0.26 | 0.021 | 0.274 | Phospholipase A2 inhibitor | 0.119 0.118 DB00369 0.274 0.018 DBMET03374 0.145 0.08 DBMET03375 | DBMET03374 | |
| 0.257 | 0.046 | 0.311 | Peptidyltransferase inhibitor | 0.311 0.021 DB00369 0.264 0.042 DBMET03374 0.281 0.032 DBMET03375 0.273 0.037 DBMET03373 | DB00369 | |
| 0.281 | 0.102 | 0.341 | Antithrombotic | 0.341 0.068 DBMET03374 0.232 0.142 DBMET03373 | DBMET03374 | |
| 0.156 | 0.001 | 0.186 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.169 0.001 DB00369 0.179 0.001 DBMET03374 0.176 0.001 DBMET03375 0.186 0.001 DBMET03373 | DBMET03373 | |
| 0.166 | 0.011 | 0.222 | Antimetabolite | 0.078 0.02 DB00369 0.222 0.008 DBMET03374 0.112 0.015 DBMET03375 0.175 0.011 DBMET03373 | DBMET03374 | |
| 0.156 | 0.003 | 0.269 | Antiviral (Hepatitis D) | 0.269 0.002 DB00369 0.156 0.003 DBMET03374 0.201 0.003 DBMET03375 0.266 0.002 DBMET03373 | DB00369 | |
| 0.152 | 0.011 | 0.565 | Carbamoyl phosphate synthetase inhibitor | 0.378 0.003 DB00369 0.382 0.003 DBMET03374 0.287 0.005 DBMET03375 0.565 0.002 DBMET03373 | DBMET03373 | |
| 0.262 | 0.122 | 0.262 | Vasodilator, coronary | 0.219 0.165 DBMET03374 0.217 0.166 DBMET03375 | ||
| 0.144 | 0.015 | 0.588 | HIV-1 reverse transcriptase inhibitor | 0.265 0.006 DB00369 0.136 0.017 DBMET03374 0.178 0.011 DBMET03375 0.588 0.003 DBMET03373 | DBMET03373 | |
| 0.184 | 0.056 | 0.184 | Phospholipase C inhibitor | 0.183 0.058 DBMET03374 | ||
| 0.107 | 0.003 | 0.451 | Thymidine phosphorylase inhibitor | 0.451 0.001 DB00369 0.059 0.004 DBMET03374 0.145 0.002 DBMET03375 0.224 0.002 DBMET03373 | DB00369 | |
| 0.192 | 0.1 | 0.199 | Hypolipemic | 0.199 0.095 DBMET03374 | DBMET03374 | |
| 0.095 | 0.007 | 0.1 | Squalene synthetase inhibitor | 0.074 0.009 DB00369 0.1 0.006 DBMET03374 0.094 0.007 DBMET03375 0.075 0.009 DBMET03373 | DBMET03374 | |
| 0.103 | 0.015 | 0.213 | Ornithine carbamoyltransferase inhibitor | 0.129 0.012 DB00369 0.097 0.017 DBMET03374 0.122 0.012 DBMET03375 0.213 0.006 DBMET03373 | DBMET03373 | |
| 0.074 | 0.006 | 0.093 | Cytokine production stimulant | 0.093 0.004 DB00369 0.045 0.044 DBMET03374 0.054 0.02 DBMET03375 0.048 0.033 DBMET03373 | DB00369 | |
| 0.121 | 0.053 | 0.139 | Chelator | 0.139 0.04 DBMET03374 0.112 0.062 DBMET03375 | DBMET03374 | |
| 0.185 | 0.117 | 0.185 | Vasodilator | 0.184 0.118 DBMET03374 | ||
| 0.075 | 0.009 | 0.132 | Thymidine kinase inhibitor | 0.085 0.008 DB00369 0.071 0.01 DBMET03374 0.083 0.008 DBMET03375 0.132 0.004 DBMET03373 | DBMET03373 | |
| 0.062 | 0.007 | 0.194 | Purinergic P2Y2 antagonist | 0.068 0.006 DB00369 0.066 0.007 DBMET03374 0.074 0.005 DBMET03375 0.194 0.002 DBMET03373 | DBMET03373 | |
| 0.073 | 0.024 | 0.318 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.238 0.005 DB00369 0.084 0.019 DBMET03374 0.133 0.01 DBMET03375 0.318 0.003 DBMET03373 | DBMET03373 | |
| 0.085 | 0.038 | 0.201 | Purinergic P2X2 antagonist | 0.129 0.017 DB00369 0.073 0.044 DBMET03374 0.117 0.022 DBMET03375 0.201 0.005 DBMET03373 | DBMET03373 | |
| 0.054 | 0.013 | 0.147 | Phosphoglycerate kinase inhibitor | 0.093 0.007 DB00369 0.057 0.012 DBMET03374 0.076 0.009 DBMET03375 0.147 0.004 DBMET03373 | DBMET03373 | |
| 0.064 | 0.034 | 0.087 | Ribonucleotide reductase inhibitor | 0.079 0.027 DBMET03374 0.087 0.024 DBMET03373 | DBMET03373 | |
| 0.081 | 0.051 | 0.081 | Interferon agonist | |||
| 0.04 | 0.013 | 0.124 | Purinergic P2X agonist | 0.043 0.011 DB00369 0.037 0.014 DBMET03374 0.045 0.011 DBMET03375 0.124 0.002 DBMET03373 | DBMET03373 | |
| 0.052 | 0.025 | 0.085 | Purinergic P2Y antagonist | 0.062 0.019 DBMET03374 0.085 0.012 DBMET03373 | DBMET03373 | |
| 0.034 | 0.007 | 0.042 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.028 0.009 DB00369 0.038 0.006 DBMET03374 0.042 0.005 DBMET03375 0.036 0.007 DBMET03373 | DBMET03375 | |
| 0.059 | 0.035 | 0.074 | Ribonucleoside-diphosphate reductase inhibitor | 0.074 0.027 DBMET03374 0.061 0.034 DBMET03373 | DBMET03374 | |
| 0.071 | 0.047 | 0.214 | Phosphofructokinase-1 inhibitor | 0.146 0.019 DB00369 0.142 0.02 DBMET03374 0.109 0.029 DBMET03375 0.214 0.01 DBMET03373 | DBMET03373 | |
| 0.155 | 0.133 | 0.155 | MAP kinase kinase 5 inhibitor | |||
| 0.037 | 0.02 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.041 0.015 DB00369 0.041 0.015 DBMET03374 | DBMET03374 | |
| 0.043 | 0.031 | 0.062 | Geranyltranstransferase inhibitor | 0.062 0.012 DBMET03373 | DBMET03373 | |
| 0.092 | 0.081 | 0.134 | Folate antagonist | 0.134 0.029 DBMET03374 0.092 0.083 DBMET03375 0.091 0.086 DBMET03373 | DBMET03374 | |
| 0.014 | 0.005 | 0.024 | Purine nucleoside phosphorylase inhibitor | 0.024 0.003 DB00369 0.017 0.004 DBMET03374 0.022 0.003 DBMET03375 0.022 0.003 DBMET03373 | DB00369 | |
| 0.01 | 0.004 | 0.022 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DB00369 0.011 0.004 DBMET03374 0.013 0.003 DBMET03375 0.022 0.002 DBMET03373 | DBMET03373 | |
| 0.026 | 0.021 | 0.028 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET03374 0.028 0.014 DBMET03373 | DBMET03373 | |
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.013 | 0.012 | 0.027 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.027 0.005 DBMET03374 0.013 0.012 DBMET03375 | DBMET03374 | |
| 0.013 | 0.012 | 0.067 | Purinergic receptor agonist | 0.013 0.012 DB00369 0.013 0.012 DBMET03374 0.015 0.011 DBMET03375 0.067 0.002 DBMET03373 | DBMET03373 | |
| 0.013 | 0.012 | 0.067 | Purinergic P2 agonist | 0.013 0.012 DB00369 0.013 0.012 DBMET03374 0.015 0.011 DBMET03375 0.067 0.002 DBMET03373 | DBMET03373 | |
| 0.089 | 0.088 | 0.148 | Adenylate kinase inhibitor | 0.103 0.063 DB00369 0.109 0.055 DBMET03374 0.148 0.027 DBMET03373 | DBMET03373 | |
| 0.01 | 0.012 | 0.057 | Purinergic P2Y agonist | 0.057 0.002 DBMET03373 | DBMET03373 | |
| 0.016 | 0.019 | 0.13 | Purinergic P2T antagonist | 0.02 0.016 DBMET03374 0.13 0.004 DBMET03373 | DBMET03373 | |
| 0.013 | 0.018 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET03373 | DBMET03373 | |
| 0.076 | 0.081 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 DBMET03374 0.085 0.058 DBMET03373 | DBMET03373 | |
| 0.03 | 0.037 | 0.04 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.03 DB00369 0.032 0.031 DBMET03374 0.04 0.013 DBMET03373 | DBMET03373 | |
| 0.114 | 0.121 | 0.23 | Protein-tyrosine phosphatase inhibitor | 0.23 0.036 DB00369 0.142 0.088 DBMET03374 | DB00369 | |
| 0.016 | 0.025 | 0.041 | Purinergic P2Y12 antagonist | 0.022 0.017 DBMET03374 0.041 0.009 DBMET03373 | DBMET03373 | |
| 0.002 | 0.011 | 0.01 | Purinergic P2Y4 agonist | 0.01 0.002 DBMET03373 | DBMET03373 | |
| 0.007 | 0.019 | 0.015 | Purinergic P2Y2 agonist | 0.011 0.007 DB00369 0.015 0.003 DBMET03373 | DBMET03373 | |
| 0.02 | 0.038 | 0.052 | Sphingosine 1-phosphate receptor 3 agonist | 0.052 0.015 DBMET03373 | DBMET03373 | |
| 0.01 | 0.029 | 0.018 | Prokineticin receptor 1 antagonist | 0.018 0.01 DB00369 | DB00369 | |
| 0.072 | 0.095 | 0.255 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 DBMET03375 0.255 0.008 DBMET03373 | DBMET03373 | |
| 0.024 | 0.053 | 0.068 | Purinergic P2X3 antagonist | 0.037 0.02 DB00369 0.035 0.024 DBMET03375 0.068 0.006 DBMET03373 | DBMET03373 | |
| 0.068 | 0.109 | 0.263 | NADH dehydrogenase inhibitor | 0.17 0.014 DB00369 0.085 0.065 DBMET03374 0.111 0.034 DBMET03375 0.263 0.007 DBMET03373 | DBMET03373 | |
| 0.071 | 0.124 | 0.299 | Adenylate cyclase inhibitor | 0.138 0.054 DB00369 0.096 0.088 DBMET03374 0.299 0.014 DBMET03373 | DBMET03373 | |
| 0.068 | 0.122 | 0.156 | Protein-tyrosine phosphatase 1B inhibitor | 0.156 0.043 DB00369 | DB00369 | |
| 0.036 | 0.091 | 0.233 | Purinergic P2 antagonist | 0.233 0.005 DBMET03373 | DBMET03373 | |
| 0.039 | 0.098 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.043 DBMET03374 0.05 0.047 DBMET03373 | DBMET03374 | |
| 0.012 | 0.075 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.033 0.006 DB00369 0.022 0.02 DBMET03373 | DB00369 | |
| 0.015 | 0.085 | 0.065 | Fumarate hydratase inhibitor | 0.039 0.02 DB00369 0.038 0.02 DBMET03374 0.065 0.009 DBMET03373 | DBMET03373 | |
| 0.029 | 0.1 | 0.095 | Argininosuccinate synthase inhibitor | 0.053 0.044 DB00369 0.095 0.02 DBMET03373 | DBMET03373 | |
| 0.007 | 0.079 | 0.022 | Purinergic P2Y1 antagonist | 0.022 0.007 DBMET03373 | DBMET03373 | |
| 0.088 | 0.16 | 0.132 | Sphingosine 1-phosphate receptor 2 agonist | 0.132 0.039 DBMET03373 | DBMET03373 | |
| 0.181 | 0.254 | 0.255 | Antibacterial | 0.222 0.205 DB00369 0.255 0.172 DBMET03373 | DBMET03373 | |
| 0.045 | 0.127 | 0.142 | Glutamate dehydrogenase inhibitor | 0.091 0.036 DB00369 0.09 0.037 DBMET03374 0.07 0.057 DBMET03375 0.142 0.017 DBMET03373 | DBMET03373 | |
| 0.022 | 0.105 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | 0.073 0.011 DB00369 0.041 0.037 DBMET03373 | DB00369 | |
| 0.01 | 0.093 | 0.032 | AMPA 2 receptor antagonist | 0.032 0.019 DB00369 | DB00369 | |
| 0.025 | 0.109 | 0.05 | Acyl-CoA dehydrogenase inhibitor | 0.05 0.043 DBMET03373 | DBMET03373 | |
| 0.095 | 0.231 | 0.211 | Platelet antagonist | 0.211 0.093 DBMET03374 | DBMET03374 | |
| 0.072 | 0.228 | 0.16 | Cell wall synthesis inhibitor | 0.16 0.057 DB00369 0.134 0.081 DBMET03373 | DB00369 | |
| 0.02 | 0.183 | 0.096 | Biliverdin reductase inhibitor | 0.072 0.03 DB00369 0.096 0.02 DBMET03373 | DBMET03373 | |
| 0.074 | 0.239 | 0.335 | Hexokinase inhibitor | 0.227 0.023 DB00369 0.15 0.079 DBMET03375 0.335 0.007 DBMET03373 | DBMET03373 | |
| 0.04 | 0.238 | 0.193 | UDP-glucose 4-epimerase inhibitor | 0.121 0.043 DB00369 0.193 0.019 DBMET03373 | DBMET03373 | |
| 0.142 | 0.375 | 0.243 | Cyclophilin D inhibitor | 0.243 0.221 DBMET03374 | DBMET03374 | |
| 0.025 | 0.292 | 0.087 | Expectorant | 0.087 0.086 DBMET03373 | DBMET03373 | |
| 0.03 | 0.326 | 0.097 | Mucolytic | 0.097 0.082 DBMET03373 | DBMET03373 | |
| 0.022 | 0.318 | 0.086 | Purinergic P2X1 antagonist | 0.086 0.022 DBMET03373 | DBMET03373 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |